Despite advances in clinical treatment and research, cancer remains the second-leading cause of death worldwide. The Yale Cancer Center, one of the very first such centers designated by the National Cancer Institute, has initiated extensive new research efforts to lead in the epidemiology, early detection, prevention, diagnosis and treatment of this disease. This discussion will feature Yale experts explaining the latest advances in their specific fields, with time for your questions.  Dr. Herbst will be joined by Lieping Chen (MD, PhD, United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, Dermatology, and Medicine (Medical Oncology), Yale School of Medicine), Katerina Politi (PhD, Co-Leader, Cancer Signaling Networks, Scientific Director, Center for Thoracic Cancers, Smilow Cancer Hospital and Yale Cancer Center), and Daniel DiMaio (MD, PhD, Deputy Director, Yale Cancer Center, Waldemar Von Zedtwitz Professor of Genetics and Professor of Molecular Biophysics and Biochemistry and of Therapeutic Radiology).